Previous Close | 2.8600 |
Open | 2.8800 |
Bid | 2.7800 x 400 |
Ask | 2.8200 x 400 |
Day's Range | 2.7700 - 2.9200 |
52 Week Range | 1.7950 - 4.7050 |
Volume | |
Avg. Volume | 737,604 |
Market Cap | 368.177M |
Beta (5Y Monthly) | 1.57 |
PE Ratio (TTM) | 69.75 |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
Organogenesis Holdings ( NASDAQ:ORGO ) Full Year 2023 Results Key Financial Results Revenue: US$433.1m (down 3.9% from...
Organogenesis Holdings Inc. (NASDAQ:ORGO) Q4 2023 Earnings Call Transcript February 29, 2024 Organogenesis Holdings Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Welcome ladies and gentlemen to the Fourth Quarter and Fiscal Year 2023 Earnings Conference Call for Organogenesis […]
Organogenesis (ORGO) delivered earnings and revenue surprises of 100% and 6.45%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?